Industry challenges for producing emergency vaccines in Europe EMA - PowerPoint PPT Presentation

Aug 11, 2023 •189 likes •278 views

Industry challenges for producing emergency vaccines in Europe EMA Lumpy Skin Disease Workshop Alasdair King Director Intergovernmental Veterinary Health Speed vs Risk Forecasting Upscaling of production Risk management

Industry challenges for producing emergency vaccines in Europe EMA Lumpy Skin Disease Workshop Alasdair King Director Intergovernmental Veterinary Health
Speed vs Risk
Forecasting • Upscaling of production • Risk management • Matching supply to demand • Improved forecasting - faster delivery 3
Presentations • Impact of vial size • Production volumes • Shipping • Impact of labelling • Variations add time 4
Logistics • Routes • Airlines • Documentation • Cold chain 5
Siting • Currently outside EU • Moving site to EU • Technology transfer • Proof of success • Testing • Other vaccines made outside EU • Is this a priority? 6
Future Requirements • Differentiate between wanted and needed • Key issues • Quality • Safety • Efficacy • Changes risk delays/reduced volumes 7
Summary • Short term vs long term aims • Industry recognises urgency • Response requires co-operation • Improving forecasting critical 8

Download Presentation

Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

Field efficacy trials for vaccines for food-producing animals Challenges faced by Industry

Field efficacy trials for vaccines for food-producing animals Challenges faced by Industry Frdric Descamps Focus group meeting, 22 June 2017, EMA, London Introduction IFAH-Europe welcomes the focus group meeting (and the vet vaccine

504 views • 18 slides

Industry perspective on challenges meeting the requirements for authorisation of vaccines in the

Industry perspective on challenges meeting the requirements for authorisation of vaccines in the EU IFAH-Europe Biologicals Working Party J. Lchenet 1 I ndustry perspective on requirem ents for vaccines Some figures (IFAH benchmark)

462 views • 22 slides

Considerations for FDA Licensure vs. Emergency Use Authorization of COVID-19 Vaccines Doran

Considerations for FDA Licensure vs. Emergency Use Authorization of COVID-19 Vaccines Doran Fink, MD, PhD FDA/CBER Office of Vaccines Research and Review ACIP COVID-19 Meeting July 29, 2020 FDA Licensure Requirement for demonstration of

772 views • 8 slides

BIOE 301 Stimulate immunity without causing disease How are vaccines made?

Summary How do vaccines work? BIOE 301 Stimulate immunity without causing disease How are vaccines made? Non-infectious vaccines Live, attenuated bacterial or viral vaccines Carrier Vaccines Lecture Ten DNA Vaccines

413 views • 7 slides

Weapons Convention: 2015 Meeting of Experts Industry Role, Challenges and Opportunities in

Biological and Toxin Weapons Convention: 2015 Meeting of Experts Industry Role, Challenges and Opportunities in Achieving BWC Objectives Phyllis Arthur Sr. Director, Vaccines, Biodefense and Diagnostics Policy August 11, 2015 1

125 views • 8 slides

BIOE 301 Lecture Ten Summary How do vaccines work? Stimulate immunity without causing

BIOE 301 Lecture Ten Summary How do vaccines work? Stimulate immunity without causing disease How are vaccines made? Non-infectious vaccines Live, attenuated bacterial or viral vaccines Carrier Vaccines DNA Vaccines

852 views • 38 slides

ETSI EMTEL (Special Committee on Emergency Communications) CHAIRMAN Ray Forbes Producing and

ETSI EMTEL (Special Committee on Emergency Communications) CHAIRMAN Ray Forbes Producing and maintaining Standards for Emergency Communications Presented by Ian Harris EMTEL Vice Chairman Consultant to Research In Motion ITU-T Workshop,

699 views • 37 slides

GSK VACCINES IN 2011 Martin Andrews Senior Vice President Global Vaccines Centre of Excellence

GSK VACCINES IN 2011 Martin Andrews Senior Vice President Global Vaccines Centre of Excellence GSK Biologicals Todays agenda GSK GSK Global GSK vaccines: vaccines vaccines vaccines key growth pipeline market in 2011 drivers 2

699 views • 30 slides

VACFA Vaccines for Africa. 10 th Annual African Vaccinology Course Challenges of introducing HPV

VACFA Vaccines for Africa. 10 th Annual African Vaccinology Course Challenges of introducing HPV Vaccination Programmes among pre- adolescence & adolescence populations Dr NR Dlamini, Chief Director: Child, Adolescent and School Health

1.14k views • 35 slides

Requirements for Vaccines in Other Regions of the World Industry Considerations 25 March 2015 1

Requirements for Vaccines in Other Regions of the World Industry Considerations 25 March 2015 1 Veterinary Vaccine Development from an Industry Perspective Global veterinary vaccine development costs and timelines have increased

401 views • 19 slides

Pneumococcal vaccines Marco Aurlio Sfadi, MD, PhD FCM da Santa Casa de So Paulo Challenges

Pneumococcal vaccines Marco Aurlio Sfadi, MD, PhD FCM da Santa Casa de So Paulo Challenges in establishing the baseline burden of disease, before implementing a vaccination program S. pneumoniae disease Endpoints: Mucosal infections

892 views • 42 slides

PROVIDING DIRECTION | PRODUCING RESULTS Funding the Pharmaceutical and Biotechnology Industry

PROVIDING DIRECTION | PRODUCING RESULTS Funding the Pharmaceutical and Biotechnology Industry Benjamin R. Bowen, Ph.D Managing Director Northland Capital Markets. How is the Creation of New Therapeutics Funded Established companies

651 views • 13 slides

Challenges and Regulation The Critical Role of Emergency Telecommunications Gisa Fuatai Purcell

Emergency Communications: Challenges and Regulation The Critical Role of Emergency Telecommunications Gisa Fuatai Purcell Head of Division, Least Developed Countries, Small Island Dev. States, and Emergency Telecoms Disasters on the rise

207 views • 20 slides

Challenges in performing field trials to support efficacy: Companion animal vaccines Dr. Klaus

Challenges in performing field trials to support efficacy: Companion animal vaccines Dr. Klaus Hellmann Association of Veterinary Consultants | 2014 Legislation and guidelines Annex 1 Directive 2001/82/EC as amended Directive 2009/9/EC

196 views • 16 slides

GSK VACCINES IN 2010 Thomas Breuer, MD, MSc Senior Vice President Head of Global Vaccines

GSK VACCINES IN 2010 Thomas Breuer, MD, MSc Senior Vice President Head of Global Vaccines Development GSK Biologicals Vaccines business characteristics Few global players and high barriers to entry Complex manufacturing Large

461 views • 33 slides

GSK VACCINES: KEY GROWTH DRIVERS Martin Andrews Senior Vice President, Global Vaccines Centre

GSK VACCINES: KEY GROWTH DRIVERS Martin Andrews Senior Vice President, Global Vaccines Centre of Excellence, GSK Biologicals Millions of children die from infectious diseases Many of these deaths are preventable By 2015 vaccines could reduce

447 views • 21 slides

Property Tax Postponement Program October 28, 2016 State Controllers Office Lindsey Ross,

Property Tax Postponement Program October 28, 2016 State Controllers Office Lindsey Ross, Manager PTP Program Materials County Guide Application Remittance Advice Notice of Lien Notice of Change form County

265 views • 5 slides

THE ILLINOIS STATE BUDGET FY18 Presentation to the Chicago Jobs Council Mitch Lifson Senior

THE ILLINOIS STATE BUDGET FY18 Presentation to the Chicago Jobs Council Mitch Lifson Senior Policy Analyst Voices for Illinois Children August 9, 2017 WLS-TV THE MONEY.. Prior to Revenue Bill Passage: Government Forecasting and

423 views • 24 slides

PROPOSED BUDGET February 21, 2017 Economic Outlook Slow Growing Regional Economy Tax base

FY 2018 CITY MANAGERS PROPOSED BUDGET February 21, 2017 Economic Outlook Slow Growing Regional Economy Tax base growth of 2% Federal government employment and policy changes High Office Vacancy Rate Need for Economic

620 views • 18 slides

Preparing for Retirement If you have questions during this webinar, please submit them via

Preparing for Retirement If you have questions during this webinar, please submit them via Secure messaging through your UC Retirement At Your Service (UCRAYS) account: https://retirementatyourservice.ucop.edu/UCRAYS/

776 views • 75 slides

Mr Brian Molefe Group Chief Executive 07 December 2011 1 PAGE TABLE OF CONTENTS OVERVI EW

PRESENTATI ON ON THE PORT OF RI CHARDS BAY Mr Brian Molefe Group Chief Executive 07 December 2011 1 PAGE TABLE OF CONTENTS OVERVI EW FUTURE GROWTH PLANS PORT DEVELOPMENT FRAMEWORK LAND USE STRATEGY LOTHAI R LI NK CAPI TAL PROJECTS 2

387 views • 38 slides

Summary of Municipal Utilities & Rural Electric Cooperatives 2010-2014 Energy Efficiency

Summary of Municipal Utilities & Rural Electric Cooperatives 2010-2014 Energy Efficiency Results Background Iowa Code 476.6(15)(c)(1)-(4) directed utilities: (those utilities not required to be rate-regulated - such as the municipal

276 views • 16 slides

LUXURY CONNECT LUXURY CONNECT 29th Feb 2012, 12 PM press launch INDIAN LUXURY PRODUCTS &

LUXURY CONNECT LUXURY CONNECT 29th Feb 2012, 12 PM press launch INDIAN LUXURY PRODUCTS & SERVICES SEGMENT India is the second fastest growing economy in the world, next only to China. 9% real GDP growth in 2010, forecasted to

404 views • 28 slides

THE FINEST HOMES DESERVE info@dermotobrien.com THE FINEST MARKETING. www.DermotOBrien.com G oinG

THE RESORT AT SINGER ISLAND #2100 PRESTIGE REAL ESTATE MARKETING PLAN The Resort at Singer Island #2100 Singer Island, Florida The Resort at Singer Island #2100 Dermot OBrien Dermot OBrien Realty phone: (561) 317-1177 contact | website

306 views • 12 slides